These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23134031)

  • 1. [Therapy-related myeloid neoplasms].
    Harada Y; Harada H
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():699-703. PubMed ID: 23134031
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy-related, donor-derived AML responding to a second allogeneic BMT.
    Jacobs JF; Brons PP; Simons A; van der Reijden BA; Hoogerbrugge PM
    Bone Marrow Transplant; 2007 Sep; 40(5):499-500. PubMed ID: 17589531
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy-related acute myeloid leukemia with t(9;11)(p12;q23) in a patient treated for acute promyelocytic leukemia.
    Annunziata M; Palmieri S; Pocali B; De Simone M; Del Vecchio L; Vicari L; Pane F; Ferrara F
    Hematol J; 2003; 4(4):289-91. PubMed ID: 12872155
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute leukemia of donor origin arising after stem cell transplantation for acute promyelocytic leukemia.
    Daly AS; Kamel-Reid S; Lipton JH; Messner HA; Kiss TL; Chun K; Busque L; Chang H
    Leuk Res; 2004 Oct; 28(10):1107-11. PubMed ID: 15289025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into leukemogenesis from therapy-related leukemia.
    Pedersen-Bjergaard J
    N Engl J Med; 2005 Apr; 352(15):1591-4. PubMed ID: 15829541
    [No Abstract]   [Full Text] [Related]  

  • 6. Myeloid leukemia after cytotoxic therapy and other hematotoxins.
    Larson RA
    J Toxicol Environ Health A; 2000 Nov; 61(5-6):381-6. PubMed ID: 11086943
    [No Abstract]   [Full Text] [Related]  

  • 7. Special clinical concerns/problems in the management of MDS and secondary acute myeloid leukemias.
    Venugopal P; Manson S; Preisler HD
    Cancer Treat Res; 2001; 108():257-65. PubMed ID: 11702603
    [No Abstract]   [Full Text] [Related]  

  • 8. Subcutaneous myeloid sarcoma.
    Geyer AS; Gill M; Husain S; Fox LP; Grossman ME
    Arch Dermatol; 2005 Jan; 141(1):104-6. PubMed ID: 15655160
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blastic crisis at the apparent onset of chronic granulocytic leukemia].
    Coliţă D; Gociu M; Butoianu E; Nicoară S; Ursea C; Coliţă A; Capătă-Stoica I; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(3):241-6. PubMed ID: 6140718
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metamorphosis of chronic myeloproliferative diseases].
    Butoianu E; Nicoară S; Coliţă A; Ursea C; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(3):223-32. PubMed ID: 6140716
    [No Abstract]   [Full Text] [Related]  

  • 11. Leukemia in donor cells after allogeneic hematopoietic stem cell transplant.
    Brunstein CG; Hirsch BA; Hammerschmidt D; McGlennen RC; Nguyen PL; Verfaillie CM
    Bone Marrow Transplant; 2002 Jun; 29(12):999-1003. PubMed ID: 12098070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of secondary leukemia.
    Rowe JM
    Leukemia; 2002 Apr; 16(4):748-50. PubMed ID: 11960361
    [No Abstract]   [Full Text] [Related]  

  • 13. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
    Larson RA
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):29-37. PubMed ID: 17336252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of therapy-related leukemia and myelodysplastic syndrome.
    Kantarjian HM; Estey EH; Keating MJ
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):81-107. PubMed ID: 7680643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy-related myelodysplastic syndrome and acute myeloid leukemia after autologous bone marrow transplantation: dosis facit venenum?
    Sill H; Olipitz W; Schimek MG
    J Clin Oncol; 2005 Nov; 23(31):8120-1; author reply 8121-2. PubMed ID: 16258113
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy-related leukemia: is the risk life-long and can we identify patients at greatest risk.
    Davies SM
    J Pediatr Hematol Oncol; 2000; 22(4):302-5. PubMed ID: 10959899
    [No Abstract]   [Full Text] [Related]  

  • 17. Type of prior genotoxic insult determines the genomic characteristics of therapy-related myeloid neoplasms.
    Ozga M; Blachly J; Eisfeld AK; Grieselhuber N; Larkin K; Walker A; Bhatnagar B; Behbehani G; Long M; Haque T; Vasu S; Zhao W; Jones D; Byrd JC; Mims AS; Saygin C
    Am J Hematol; 2021 Jul; 96(7):E223-E225. PubMed ID: 33761147
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ph1 and C group marker in a acute leukemia associated with noramidopyrine treatment (author's transl)].
    Moraine C; Brémond JL; Despert F; Leroy J; Leroux ME; Maillet M
    Nouv Rev Fr Hematol; 1974; 14(4):461-70. PubMed ID: 4280556
    [No Abstract]   [Full Text] [Related]  

  • 19. Tracing the origin of cytogenetic anomalies in acute myeloid leukaemia following multiple myeloma.
    Georgia S; Dieter-Kurt H
    Br J Haematol; 2004 Aug; 126(4):442. PubMed ID: 15287936
    [No Abstract]   [Full Text] [Related]  

  • 20. Childhood myeloid leukaemias.
    Hall GW
    Best Pract Res Clin Haematol; 2001 Sep; 14(3):573-91. PubMed ID: 11640870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.